356 related articles for article (PubMed ID: 26494229)
1. Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis.
Engelbertsen D; Foks AC; Alberts-Grill N; Kuperwaser F; Chen T; Lederer JA; Jarolim P; Grabie N; Lichtman AH
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2526-35. PubMed ID: 26494229
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of experimental atherosclerosis by interleukin-19.
Ellison S; Gabunia K; Kelemen SE; England RN; Scalia R; Richards JM; Orr AW; Traylor JG; Rogers T; Cornwell W; Berglund LM; Goncalves I; Gomez MF; Autieri MV
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2316-24. PubMed ID: 23950143
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
4. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
Park JG; Xu X; Cho S; Lee AH
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of HIF1α in Antigen-Presenting Cells Aggravates Atherosclerosis and Type 1 T-Helper Cell Responses in Mice.
Chaudhari SM; Sluimer JC; Koch M; Theelen TL; Manthey HD; Busch M; Caballero-Franco C; Vogel F; Cochain C; Pelisek J; Daemen MJ; Lutz MB; Görlach A; Kissler S; Hermanns HM; Zernecke A
Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2316-25. PubMed ID: 26404487
[TBL] [Abstract][Full Text] [Related]
6. Constitutive GITR Activation Reduces Atherosclerosis by Promoting Regulatory CD4+ T-Cell Responses-Brief Report.
Meiler S; Smeets E; Winkels H; Shami A; Pascutti MF; Nolte MA; Beckers L; Weber C; Gerdes N; Lutgens E
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1748-52. PubMed ID: 27444204
[TBL] [Abstract][Full Text] [Related]
7. IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.
Mantani PT; Dunér P; Bengtsson E; Alm R; Ljungcrantz I; Söderberg I; Sundius L; To F; Nilsson J; Björkbacka H; Fredrikson GN
PLoS One; 2015; 10(1):e0117255. PubMed ID: 25629516
[TBL] [Abstract][Full Text] [Related]
8. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
[TBL] [Abstract][Full Text] [Related]
9. Acceleratory effects of ambient fine particulate matter on the development and progression of atherosclerosis in apolipoprotein E knockout mice by down-regulating CD4
Wan Q; Liu Z; Yang M; Wu J
Toxicol Lett; 2019 Nov; 316():27-34. PubMed ID: 31513887
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of IL-2 reduces atherosclerosis via expansion of regulatory T cells.
Dietrich T; Hucko T; Schneemann C; Neumann M; Menrad A; Willuda J; Atrott K; Stibenz D; Fleck E; Graf K; Menssen HD
Atherosclerosis; 2012 Feb; 220(2):329-36. PubMed ID: 22062588
[TBL] [Abstract][Full Text] [Related]
11. Foamy monocytes form early and contribute to nascent atherosclerosis in mice with hypercholesterolemia.
Xu L; Dai Perrard X; Perrard JL; Yang D; Xiao X; Teng BB; Simon SI; Ballantyne CM; Wu H
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1787-97. PubMed ID: 26112011
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with cilostazol and pravastatin improves antiatherogenic effects in low-density lipoprotein receptor knockout mice.
Park KY; Heo TH
Cardiovasc Ther; 2018 Dec; 36(6):e12476. PubMed ID: 30378752
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
14. B- and T-lymphocyte attenuator stimulation protects against atherosclerosis by regulating follicular B cells.
Douna H; Amersfoort J; Schaftenaar FH; Kröner MJ; Kiss MG; Slütter B; Depuydt MAC; Bernabé Kleijn MNA; Wezel A; Smeets HJ; Yagita H; Binder CJ; Bot I; van Puijvelde GHM; Kuiper J; Foks AC
Cardiovasc Res; 2020 Feb; 116(2):295-305. PubMed ID: 31150053
[TBL] [Abstract][Full Text] [Related]
15. Impaired Autophagy in CD11b
Clement M; Raffort J; Lareyre F; Tsiantoulas D; Newland S; Lu Y; Masters L; Harrison J; Saveljeva S; Ma MKL; Ozsvar-Kozma M; Lam BYH; Yeo GSH; Binder CJ; Kaser A; Mallat Z
Circ Res; 2019 Nov; 125(11):1019-1034. PubMed ID: 31610723
[TBL] [Abstract][Full Text] [Related]
16. Anti-TIM-1 Monoclonal Antibody (RMT1-10) Attenuates Atherosclerosis By Expanding IgM-producing B1a Cells.
Hosseini H; Yi L; Kanellakis P; Cao A; Tay C; Peter K; Bobik A; Toh BH; Kyaw T
J Am Heart Assoc; 2018 Jun; 7(13):. PubMed ID: 29936416
[TBL] [Abstract][Full Text] [Related]
17. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
Butcher MJ; Waseem TC; Galkina EV
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions.
Brown AL; Zhu X; Rong S; Shewale S; Seo J; Boudyguina E; Gebre AK; Alexander-Miller MA; Parks JS
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2122-30. PubMed ID: 22814747
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice.
Hirase T; Hara H; Miyazaki Y; Ide N; Nishimoto-Hazuku A; Fujimoto H; Saris CJ; Yoshida H; Node K
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H420-9. PubMed ID: 23729211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]